Blog Downloads

 

Some Blog materials can be downloaded only by EAA ARC members. Please log in here!

September 08, 2020 06:51 PM

ESG fails to immunize stocks against the COVID-19 market crash

Posted by Philip Joos

Environmental, Social and Governance (ESG) investments are praised worldwide as the solution to environmental, social and societal problems, and would be the best vaccine during the Covid-19 crisis. Our research findings suggest that this is not the case, and that traditional measures such as liquidity and innovative capacity better describe crisis resilience. While corporate social responsibility companies may benefit in the longer term, it is advisable for investors to be critical of funds that promote 'ESG' as a crisis vaccine in the short term.  

Although institutional investors, fund managers and the international financial press often claim otherwise, ESG factors do not lead to better stock market performance in times of crisis. An analysis among 1,600 U.S. companies shows that a higher ESG performance does not make companies more resilient to the negative stock market impact of the corona pandemic. Sustainable investors appear to perform even worse during periods of stock market recovery.

We also show that ESG investments only account for 1% of the stock market returns of companies during the Covid crisis. ESG also has no predictive value for how a company will perform in the event of a subsequent crisis, in contrast to - again - the combination of financial flexibility and innovative power of a company (both measured from a company's financial statements), and traditional risk, industry and growth factors. Our study has implications for investors and enforcement agencies, including SEC and European corporate reporting watchdogs. 

Further readings:

Harvard Law School blog: https://corpgov.law.harvard.edu/2020/09/08/esg-didnt-immunize-stocks-against-the-covid-19-market-crash/

Financial Times Moral Money discussion: https://www.ft.com/content/57911840-599b-420f-be5a-956bb949929b

SSRN link: Demers, Elizabeth and Hendrikse, Jurian and Joos, Philip and Lev, Baruch Itamar, ESG Didn’t Immunize Stocks Against the COVID-19 Market Crash (August 17, 2020). Available at SSRN: https://ssrn.com/abstract=3675920  or  http://dx.doi.org/10.2139/ssrn.3675920

 

Share this:

Tags:

About Philip Joos

TILBURG UNIVERSITY
Past-President EAA, Professor of Accounting, Tilburg University and TIAS School for Business and Society

My research is situated in the area of empirical financial accounting. My dissertation research at Stanford University focused on earnings prediction and accounting-based equity valuation, with a specific application in the pharmaceutical and...

View Full Profile

Calendar

M T W T F S S
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30